...
首页> 外文期刊>The Journal of Physiology >Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide-binding domains.
【24h】

Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide-binding domains.

机译:沃克-A赖氨酸464在囊性纤维化跨膜电导调节剂中的突变揭示了其核苷酸结合结构域之间的功能相互作用。

获取原文
获取原文并翻译 | 示例

摘要

The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel bears two nucleotide-binding domains (NBD1 and NBD2) that control its ATP-dependent gating. Exactly how these NBDs control gating is controversial. To address this issue, we examined channels with a Walker-A lysine mutation in NBD1 (K464A) using the patch clamp technique. K464A mutants have an ATP dependence (EC(50) approximate 60 microM) and opening rate at 2.75 mM ATP (approximately 2.1 s(-1)) similar to wild type (EC(50) approximate 97 microM; approximately 2.0 s(-1)). However, K464A's closing rate at 2.75 mM ATP (approximately 3.6 s(-1)) is faster than that of wild type (approximately 2.1 s(-1)), suggesting involvement of NBD1 in nucleotide-dependent closing. Delay of closing in wild type by adenylyl imidodiphosphate (AMP-PNP), a non-hydrolysable ATP analogue, is markedly diminished in K464A mutants due to reduction in AMP-PNP's apparent on-rate and acceleration of its apparent off-rate (approximately 2- and approximately 10-fold, respectively). Since the delay of closing by AMP-PNP is thought to occur via NBD2, K464A's effect on the NBD2 mutant K1250A was examined. In sharp contrast to K464A, K1250A single mutants exhibit reduced opening (approximately 0.055 s(-1)) and closing (approximately 0.006 s(-1)) rates at millimolar [ATP], suggesting a role for K1250 in both opening and closing. At millimolar [ATP], K464A-K1250A double mutants close approximately 5-fold faster (approximately 0.029 s(-1)) than K1250A but open with a similar rate (approximately 0.059 s(-1)), indicating an effect of K464A on NBD2 function. In summary, our results reveal that both of CFTR's functionally asymmetric NBDs participate in nucleotide-dependent closing, which provides important constraints for NBD-mediated gating models.
机译:囊性纤维化跨膜电导调节剂(CFTR)氯化物通道带有两个核苷酸结合域(NBD1和NBD2),可控制其ATP依赖性门控。这些NBD如何控制选通到底是有争议的。为了解决此问题,我们使用膜片钳技术检查了NBD1(K464A)中具有Walker-A赖氨酸突变的通道。 K464A突变体具有ATP依赖性(EC(50)约60 microM)和2.75 mM ATP(约2.1 s(-1))处的打开速率类似于野生型(EC(50)约97 microM;约2.0 s(-1) ))。但是,K464A在2.75 mM ATP处的闭合速率(约3.6 s(-1))比野生型(约2.1 s(-1))快,表明NBD1参与了核苷酸依赖性闭合。由于AMP-PNP的表观导通速率降低和表观失速率的加速(大约2,ANP-PNP)(一种不可水解的ATP类似物),野生型闭合延迟在K464A突变体中明显减少。 -和分别大约10倍)。由于认为AMP-PNP闭合延迟是通过NBD2发生的,因此研究了K464A对NBD2突变体K1250A的作用。与K464A形成鲜明对比的是,K1250A单个突变体在毫摩尔[ATP]时显示出降低的打开(大约0.055 s(-1))和关闭(大约0.006 s(-1))速率,表明K1250在打开和关闭中均起作用。在毫摩尔[ATP]时,K464A-K1250A双突变体的关闭速度比K1250A快5倍左右(约0.029 s(-1)),但打开速度相似(约0.059 s(-1)),表明K464A对NBD2功能。总而言之,我们的研究结果表明,CFTR的两个功能不对称NBD均参与核苷酸依赖性关闭,这为NBD介导的门控模型提供了重要的约束条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号